Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mast Cells, Mastocytosis, and Related Disorders.

Literature DB >> 26154789

Mast Cells, Mastocytosis, and Related Disorders.

Theoharis C Theoharides, Peter Valent, Cem Akin.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2015 PMID： 26154789 DOI： 10.1056/NEJMra1409760

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

106 in total

1. Characterization of Mast Cell Activation Syndrome.

Authors: Lawrence B Afrin; Sally Self; Jeremiah Menk; John Lazarchick
Journal: Am J Med Sci Date: 2016-12-16 Impact factor: 2.378

Review 2. The role of lymphocytes in the development and treatment of alopecia areata.

Authors: Hongwei Guo; Yabin Cheng; Jerry Shapiro; Kevin McElwee
Journal: Expert Rev Clin Immunol Date: 2015-09-07 Impact factor: 4.473

3. Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis.

Authors: M Jawhar; J Schwaab; S Schnittger; M Meggendorfer; M Pfirrmann; K Sotlar; H-P Horny; G Metzgeroth; S Kluger; N Naumann; C Haferlach; T Haferlach; P Valent; W-K Hofmann; A Fabarius; N C P Cross; A Reiter
Journal: Leukemia Date: 2015-10-14 Impact factor: 11.528

Review 4. Mast Cells and Anaphylaxis.

Authors: Phil Lieberman; Lene Heise Garvey
Journal: Curr Allergy Asthma Rep Date: 2016-03 Impact factor: 4.806

10. Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism.

Authors: Arti B Patel; Irene Tsilioni; Susan E Leeman; Theoharis C Theoharides
Journal: Proc Natl Acad Sci U S A Date: 2016-09-23 Impact factor: 11.205

Mast Cells, Mastocytosis, and Related Disorders.

1. Characterization of Mast Cell Activation Syndrome.

Review 2. The role of lymphocytes in the development and treatment of alopecia areata.

3. Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis.

Review 4. Mast Cells and Anaphylaxis.

Review 5. The new tool "KIT" in advanced systemic mastocytosis.

Review 6. Hereditary Alpha-Tryptasemia: a Commonly Inherited Modifier of Anaphylaxis.

7. Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells.

Review 8. Interactions between mesenchymal stem cells and the immune system.

9. Autism and Allergy - Are They Linked?

10. Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism.